Top Stories
-
"For so many reasons, participating in the TL1 program was truly a career-changing experience", says Christina Eckhardt, "culminated in a faculty position here at CUIMC."
Topic
-
Interview with Hiral Shah, MD, assistant professor of neurology, about her work addressing the health disparities for Parkinson's disease diagnosis and treatment faced by minority communities.
Topic
-
Presented each year to faculty on the Columbia University Irving Medical Center campus in recognition of their outstanding guidance and support.
Topic
-
Dr. Rachel Shelton, co-director of the Community Engagement Core Resource, and director of the Implementation Science Initiative, has co-authored a new paper in the Annals of Emergency Medicine.
Topic
Latest News
- March 13, 2020
Launch of new Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN)
Topic
- February 10, 2020
The Irving Institute and Department of Epidemiology announce the 2020-2021 Intervention-and-Implementation Science pilot awardees
Topic
- November 21, 2019
Columbia Officials Present at White House Discussion on Opioid Overdose and Response in Higher Education
Topic
- September 19, 2019
Columbia University Opioid Crisis Response - An Update
Topic
- June 17, 2019
Precision Medicine Resource Co-Directors Launch Annals of Internal Medicine Article Series
Topic
- June 17, 2019
Irving Institute’s Krzysztof Kiryluk, Co-Director of the Precision Medicine Resource, Published in the New England Journal of Medicine
Topic
- May 22, 2019
The Irving Institute Joins the Action Collaborative on Countering the U.S. Opioid Epidemic
Topic
- April 30, 2019
Columbia pediatricians found that mothers of infants prefer facts, not criticism, about the health risks of sugary drinks.
Topic
- June 22, 2018
Over 200 researchers, industry partners and community members gathered to advance new efforts to address the opioid crisis.
Topic
- January 9, 2018
The Irving Institute for Clinical and Translational Research convened a group of Columbia University experts across the spectrum of opioid research.
Topic
